Genesis Molecular AI
AI-driven drug discovery for pharmaceutical and biotech partners, using machine learning and molecular simulation
Highlights
- New on EvolcAdded 2026-11-14
About Genesis Molecular AI
Genesis Molecular AI develops GEMS, an AI platform for small-molecule drug discovery, and Pearl, a foundation model that predicts protein–ligand structures. Its technology combines machine learning, physics-based simulation and chemistry workflows to generate and evaluate drug candidates.
The company uses GEMS for its own drug-discovery programs and for collaborations with pharmaceutical partners, including Gilead and Incyte. Chemists use the platform to generate candidate molecules, predict properties and guide design decisions.
Founded in 2019, Genesis is headquartered in San Mateo, California, with addresses in San Diego and New York. Its open roles include machine-learning research, software engineering, computational chemistry and drug development.
Product: GEMS drug-discovery platform and Pearl foundation model for molecular design and protein–ligand structure prediction.
Jobs at Genesis Molecular AI
Open roles at Genesis Molecular AI in the Americas (3)
United States 3. From Genesis Molecular AI's careers page or applicant tracking system; each role links to the employer.
- Computational Chemistry Intern - 2027 · San Mateo, United States
- ML & Molecular Simulation Scientist · San Mateo, United States
- Software Engineer - Core Infrastructure · San Mateo, United States
More biotech & pharma companies
Gilead
Develops CAR T-cell therapies and other cell therapy treatments for people with cancerGilead
Biopharmaceutical company developing and delivering therapies for serious diseases, including virology, oncology and inflammation treatmentsGinkgo Bioworks
Autonomous lab systems and cloud-based biology R&D services for biotechnology and life sciences organizationsNew on EvolcGladstone
Disease-focused biomedical research and scientific training for patients, researchers, and the medical communityNew on EvolcHAYA Therapeutics
Develops RNA-guided medicines that target non-coding RNAs in disease, with Eli Lilly as a collaboration partnerIambic Therapeutics
AI-enabled drug discovery and development for pharmaceutical and biotechnology partnersRemote-friendly
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- WebflowHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
Hosting
- AWSHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.